Co-Sponsor
Thursday, November 14th Agenda
10:30AM ET
Marvel Biosciences Corp.
OTCQB: MBCOF | TSXV: MRVL
Industry: Therapeutic drug development
Mark Williams, Chief Science Officer, Director
11:00AM ET
Cognition Therapeutics, Inc.
Nasdaq: CGTX
Industry: Biotech – Neurodegenerative Disorders
Lisa Ricciardi, CEO
John Doyle, CFO
11:30AM ET
ZyVersa Therapeutics, Inc.
Nasdaq: ZVSA
Industry: Biopharma – Inflammatory and Renal Diseases
Stephen C. Glover, Co-founder, Chairman, CEO & President
Moderated by: Brad Sorensen, CFA, Senior Equity Research Analyst with Zacks Small-Cap Research
12:00PM ET
Dermata Therapeutics, Inc.
Nasdaq: DRMA
Industry: Biotech - Skin Diseases
Gerry Proehl, Chairman, President & CEO
1:00PM ET
NeuroBo Pharmaceuticals, Inc.
Nasdaq: NRBO
Industry: Biotech - Cardiometabolic Diseases
HH Kim, CEO & President
Marshall Woodworth, CFO
{"@context": "https://schema.org","@type": "Event","name": "Life Sciences Investor Forum","startDate": "2024-11-14T09:00:00-05:00","eventAttendanceMode": "OnlineEventAttendanceMode","image": ["https://otcmarkets.gcs-web.com/static-files/437fc1c3-ca26-4d39-a781-a357d5847908","https://otcmarkets.gcs-web.com/static-files/3db571b2-b29d-4d02-876f-72d71238ae2f","https://otcmarkets.gcs-web.com/static-files/782beb53-55a6-4811-adff-7757e116f0f4"],"location":{"@type": "VirtualLocation","url": "https://www.virtualinvestorconferences.com/events/event-details/life-sciences-investor-forum-6"},"description": "Virtual Investor Conferences combine leading-edge online conferencing and investor communications capabilities with a comprehensive global investor audience network."}